Pulmonary disease, chronic obstructive Trials in Shreveport, United States
Conditions / Pulmonary disease, chronic obstructive / Shreveport, United States
Research into Pulmonary disease, chronic obstructive spans multiple therapeutic approaches and trial phases.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00268216 | Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00862641 | A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE4 |
| NCT00463567 | 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2/PHASE3 |
| NCT00387088 | Tiotropium / Respimat One Year Study in COPD. | COMPLETED | PHASE3 |
| NCT01126437 | Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT00400153 | Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00452400 | Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. | COMPLETED | PHASE2 |
| NCT02164513 | A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT02296138 | Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. | COMPLETED | PHASE3 |
| NCT00144339 | Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients | COMPLETED | PHASE3 |